4//SEC Filing
MCGRATH JOHN 4
Accession 0001209191-17-061602
CIK 0001604464other
Filed
Nov 16, 7:00 PM ET
Accepted
Nov 17, 6:24 PM ET
Size
8.3 KB
Accession
0001209191-17-061602
Insider Transaction Report
Form 4
MCGRATH JOHN
Chief Financial Officer
Transactions
- Exercise/Conversion
Restricted Stock Units
2017-11-15−7,697→ 5,132 total(indirect: See Footnote)→ Common Stock (7,697 underlying) - Exercise/Conversion
Common Stock
2017-11-15+7,697→ 128,654 total
Footnotes (5)
- [F1]Shares issued upon settlement of vested restricted stock units ("RSUs").
- [F2]Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock or a cash settlement.
- [F3]The RSUs were granted with both (a) a liquidity event-based vesting condition and (b) a service-based vesting condition, both of which conditions must be satisfied in order for the RSUs to vest. The liquidity event-based condition was satisfied upon the closing of the Issuer's initial public offering (the "IPO"). The shares that vested on the closing date of the IPO, and the shares that vested thereafter through May 15, 2015, were settled on May 15, 2015. The service-based vesting condition provides that 25% of the total number of shares on January 6, 2015 and 1/48th of the total number of shares monthly thereafter, subject to the holder's continuous service through each such date.
- [F4]The earlier of (i) December 12, 2020 or (ii) the recipient's termination date.
- [F5]The shares are held by the David B. Horowitz and John McGrath Jr. Revocable Living Trust dated 6/3/11, of which the Reporting Person is trustee.
Documents
Issuer
Atara Biotherapeutics, Inc.
CIK 0001604464
Entity typeother
Related Parties
1- filerCIK 0001205442
Filing Metadata
- Form type
- 4
- Filed
- Nov 16, 7:00 PM ET
- Accepted
- Nov 17, 6:24 PM ET
- Size
- 8.3 KB